What is Zacks Research’s Forecast for MRSH Q3 Earnings?

Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) – Analysts at Zacks Research dropped their Q3 2026 EPS estimates for shares of Marsh & McLennan Companies in a report issued on Tuesday, August 11th. Zacks Research analyst Team now anticipates that the financial services provider will post earnings of $1.95 per share for the quarter, down from their previous estimate of $1.97. The consensus estimate for Marsh & McLennan Companies’ current full-year earnings is $10.43 per share. Zacks Research also issued estimates for Marsh & McLennan Companies’ Q4 2026 earnings at $2.19 EPS, FY2026 earnings at $10.40 EPS, Q1 2027 earnings at $3.49 EPS, Q2 2027 earnings at $3.01 EPS, Q3 2027 earnings at $2.21 EPS, Q4 2027 earnings at $2.52 EPS, FY2027 earnings at $11.23 EPS, Q1 2028 earnings at $3.76 EPS, Q2 2028 earnings at $3.38 EPS and FY2028 earnings at $12.13 EPS.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last posted its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07. The company had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis.

Several other research analysts have also weighed in on MRSH. UBS Group boosted their price target on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Citigroup cut shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price for the company. in a research note on Wednesday, July 22nd. Keefe, Bruyette & Woods upped their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research report on Friday, April 17th. Wells Fargo & Company lifted their price objective on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 22nd. Finally, Cantor Fitzgerald upped their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus price target of $201.94.

Get Our Latest Stock Report on MRSH

Marsh & McLennan Companies Stock Performance

MRSH opened at $191.14 on Wednesday. The stock’s 50-day moving average is $176.05. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $213.80. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The company has a market capitalization of $91.21 billion, a price-to-earnings ratio of 23.37, a PEG ratio of 2.74 and a beta of 0.59.

Marsh & McLennan Companies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd will be given a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date of this dividend is Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 48.41%.

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of the firm’s stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the sale, the insider owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 36,469 shares of company stock valued at $6,291,345 in the last ninety days. Company insiders own 0.38% of the company’s stock.

Institutional Trading of Marsh & McLennan Companies

Several institutional investors have recently added to or reduced their stakes in the company. Solstein Capital LLC acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth $25,000. Asset Dedication LLC bought a new position in Marsh & McLennan Companies during the first quarter worth about $25,000. SHP Wealth Management bought a new stake in Marsh & McLennan Companies in the 4th quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $27,000. Finally, Golden State Wealth Management LLC bought a new position in shares of Marsh & McLennan Companies during the fourth quarter worth approximately $27,000. 87.99% of the stock is currently owned by institutional investors.

Trending Headlines about Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

  • Positive Sentiment: Zacks Research increased its FY2026 EPS estimate to $10.40 from $10.33, FY2027 to $11.23 from $11.19, and FY2028 to $12.13 from $11.93. The firm also raised estimates for Q4 2026, Q1 and Q2 2027, and Q1 and Q2 2028, suggesting improving expectations for Marsh & McLennan’s longer-term earnings growth. Zacks Research earnings estimate updates
  • Positive Sentiment: Marsh McLennan’s MMA business plans to acquire Accel, expanding its Midwest insurance presence and adding agribusiness, employee benefits, wealth management and retirement capabilities. The deal could strengthen geographic reach and broaden revenue opportunities, although financial terms were not provided. Marsh’s MMA to Acquire Accel
  • Neutral Sentiment: The current full-year consensus EPS estimate is $10.43, slightly above Zacks Research’s $10.40 forecast for FY2026. This indicates that the positive revisions have not yet translated into a broad increase in the overall consensus view.
  • Neutral Sentiment: Analysts collectively assign MRSH an average “Hold” recommendation, indicating balanced expectations following the recent earnings outlook updates. Marsh & McLennan Given Average Hold Recommendation
  • Negative Sentiment: Zacks Research lowered its Q3 2026 EPS estimate to $1.95 from $1.97, Q3 2027 to $2.21 from $2.24, and Q4 2027 to $2.52 from $2.61. These reductions partially offset the upward revisions and may limit near-term enthusiasm.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Articles

Earnings History and Estimates for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.